Cancer cells downregulate HLA-I expression by destroying the stability of β2-microglobulin, which could cause the loss of heterozygosity (LOH) of HLA-I (Challa-Malladi et al., 2011; Bernal et al., 2012). The gene discussed is HLA-G; the disease is cancer.